These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10676429)

  • 1. Uncertainty in risk assessment. Current efforts and future hopes.
    Bailer AJ
    Ann N Y Acad Sci; 1999; 895():367-72. PubMed ID: 10676429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sources of uncertainty in dose-response modeling of epidemiological data for cancer risk assessment.
    Stayner L; Bailer AJ; Smith R; Gilbert S; Rice F; Kuempel E
    Ann N Y Acad Sci; 1999; 895():212-22. PubMed ID: 10676419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common themes at the workshop on uncertainty in the risk assessment of environmental and occupational hazards.
    Bailar JC; Bailer AJ
    Ann N Y Acad Sci; 1999; 895():373-6. PubMed ID: 10676430
    [No Abstract]   [Full Text] [Related]  

  • 4. An overview of human exposure modeling activities at the USEPA's National Exposure Research Laboratory.
    Furtaw EJ
    Toxicol Ind Health; 2001 Jun; 17(5-10):302-14. PubMed ID: 12539877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncertainty in risk characterization of weak carcinogens.
    Yamaguchi N
    Ann N Y Acad Sci; 1999; 895():338-47. PubMed ID: 10676426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncertainty in estimating exposure using a toxicokinetic model. The example of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Salvan A; Thomaseth K; Bortot P; Sartori N
    Ann N Y Acad Sci; 1999; 895():125-40. PubMed ID: 10676413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncertainty in risk characterization and communication. Discussion.
    Woodward A
    Ann N Y Acad Sci; 1999; 895():365-6. PubMed ID: 10676428
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk assessment--the mother of all uncertainties. Disciplinary perspectives on uncertainty in risk assessment.
    Bailar JC; Bailer AJ
    Ann N Y Acad Sci; 1999; 895():273-85. PubMed ID: 10676423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scenario-model-parameter: a new method of cumulative risk uncertainty analysis.
    Moschandrea DJ; Karuchit S
    Environ Int; 2002 Sep; 28(4):247-61. PubMed ID: 12220111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of small effect sizes in occupational and environmental neurotoxicology: individual versus population risk.
    Bellinger DC
    Neurotoxicology; 2007 Mar; 28(2):245-51. PubMed ID: 16806481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Precautionary Principle and statistical approaches to uncertainty.
    Keiding N; Budtz-Jørgensen E
    Int J Occup Med Environ Health; 2004; 17(1):147-51. PubMed ID: 15212218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population effects and variability.
    Dorne JL; Amzal B; Bois F; Crépet A; Tressou J; Verger P
    Methods Mol Biol; 2012; 929():521-81. PubMed ID: 23007442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of expert judgment in exposure assessment. Part I. Characterization of personal exposure to benzene.
    Walker KD; Evans JS; MacIntosh D
    J Expo Anal Environ Epidemiol; 2001; 11(4):308-22. PubMed ID: 11571610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment.
    Makris SL; Thompson CM; Euling SY; Selevan SG; Sonawane B
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):530-46. PubMed ID: 19085945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating uncertainty to strengthen epidemiologic data for use in human health risk assessments.
    Burns CJ; Wright JM; Pierson JB; Bateson TF; Burstyn I; Goldstein DA; Klaunig JE; Luben TJ; Mihlan G; Ritter L; Schnatter AR; Symons JM; Yi KD
    Environ Health Perspect; 2014 Nov; 122(11):1160-5. PubMed ID: 25079138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of uncertainty and variability in residential radon cancer risks.
    Krewski D; Rai SN; Zielinski JM; Hopke PK
    Ann N Y Acad Sci; 1999; 895():245-72. PubMed ID: 10676422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying biomarker research.
    Bennett DA; Waters MD
    Environ Health Perspect; 2000 Sep; 108(9):907-10. PubMed ID: 11017898
    [No Abstract]   [Full Text] [Related]  

  • 18. On the translation of uncertainty from toxicokinetic to toxicodynamic models--the TCDD example.
    Heinzl H; Mittlböck M; Edler L
    Chemosphere; 2007 Apr; 67(9):S365-74. PubMed ID: 17224175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of endocrine disruptors: approaches, issues, and uncertainties.
    Chen CW
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():20-3. PubMed ID: 11820607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using molecular epidemiology in assessing exposure for risk assessment.
    Schulte PA; Waters M
    Ann N Y Acad Sci; 1999; 895():101-11. PubMed ID: 10676411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.